INSM vs LYB · rev $731.5M vs P/E 21, rev $16.37B
Insmed Inc (INSM) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Insmed Inc (INSM) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported INSM revenue for 2026-06-30 was $731.5M. Net income was -$176.8M. INSM currently screens at market cap $20.42B.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
INSM currently screens at market cap $20.42B. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the INSM and LYB stock pages for the full models.
Not investment advice.